| DNA repair and resistance to topoisomerase I inhibitors: mechanisms, biomarkers and therapeutic targets M Alagoz, D C Gilbert, S El-Khamisy, A J Chalmers Current medicinal chemistry 19 (23), 3874-3885, 2012 | 96 | 2012 |
| SETDB1, HP1 and SUV39 promote repositioning of 53BP1 to extend resection during homologous recombination in G2 cells M Alagoz, Y Katsuki, H Ogiwara, T Ogi, A Shibata, A Kakarougkas, ... Nucleic acids research 43 (16), 7931-7944, 2015 | 85 | 2015 |
| TDP1 deficiency sensitizes human cells to base damage via distinct topoisomerase I and PARP mechanisms with potential applications for cancer therapy M Alagoz, OS Wells, SF El-Khamisy Nucleic acids research 42 (5), 3089-3103, 2014 | 85 | 2014 |
| ATM deficiency results in accumulation of DNA-topoisomerase I covalent intermediates in neural cells M Alagoz, SC Chiang, A Sharma, SF El-Khamisy PloS one 8 (4), e58239, 2013 | 76 | 2013 |
| Deficiency in origin licensing proteins impairs cilia formation: implications for the aetiology of Meier-Gorlin syndrome T Stiff, M Alagoz, D Alcantara, E Outwin, HG Brunner, EMHF Bongers, ... PLoS genetics 9 (3), e1003360, 2013 | 75 | 2013 |
| Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13. 1-21 M Tavassoli, H Steingrimsdottir, E Pierce, X Jiang, M Alagoz, F Farzaneh, ... British journal of cancer 74 (1), 115-119, 1996 | 70 | 1996 |
| Advance genome editing technologies in the treatment of human diseases: CRISPR therapy M Alagoz, N Kherad International journal of molecular medicine 46 (2), 521-534, 2020 | 31 | 2020 |
| Effects of indoleamines on sperm motility in vitro TÖ Irez, H Senol, M Alagöz, C Basmaciogullari, F Turan, D Kuru, ... Human Reproduction 7 (7), 987-990, 1992 | 29 | 1992 |
| RNA sequencing and its applications in cancer and rare diseases S Ergin, N Kherad, M Alagoz Molecular biology reports 49 (3), 2325-2333, 2022 | 27 | 2022 |
| The use of aniline blue chromatin condensation test on prediction of pregnancy in mild male factor and unexplained male infertility T Irez, N Dayioglu, M Alagöz, S Karatas, O Güralp Andrologia 50 (10), e13111, 2018 | 19 | 2018 |
| New mutations in KCNT2 gene causing early infantile epileptic encephalopathy type 57: Case study and literature review M Alagoz, N Kherad, S Bozkurt, A Yuksel Acta Biochimica Polonica 67 (3), 431-434, 2020 | 8 | 2020 |
| A novel mutation in the SERAC1 gene correlates with the severe manifestation of the MEGDEL phenotype, as revealed by whole‑exome sequencing M Alagoz, N Kherad, S Turkmen, H Bulut, A Yuksel Experimental and Therapeutic Medicine 19 (6), 3505-3512, 2020 | 7 | 2020 |
| The new CIC mutation associates with mental retardation and severity of seizure in turkish child with a rare class I glucose-6-phosphate dehydrogenase deficiency M Alagoz, N Kherad, E Gunger, S Kaymaz, A Yuksel Journal of Molecular Neuroscience 70, 2077-2084, 2020 | 5 | 2020 |
| New genetic approaches for early diagnosis and treatment of autism spectrum disorders M Alagoz, N Kherad, M Gavaz, A Yuksel Review Journal of Autism and Developmental Disorders 6, 367-380, 2019 | 3 | 2019 |
| Glioblastoma multiforma tedavisinde kanser kök hücrelerinin temozolomide karşı oluşturdukları direnç M ALAGOZ Sakarya Tıp Dergisi 8 (2), 379-387, 2018 | 3 | 2018 |
| Loss of wild-type p53 and C-erbb2 amplification correlates with high-grade breast carcinomas M TAVASSOLI, M ALAGOZ, J LEE, BR GIBSON, F FARZANEH, ... International Journal of Oncology 6 (1), 181-186, 1995 | 3 | 1995 |
| DLG3 Impairment Caused by Missense Variants in Non-Syndromic X-Linked Mental Retardation M Alagoz, N Kherad, HA Solgun, A Ozkılıc, ES Aslan, S Bozkurt, ... | 1 | 2021 |
| SETBP1 Geninde Mental Retardasyon Tip 29 Sendromuyla Ilişkili Yeni Mutasyon Tanımlanması: Olgu Sunumu M ALAGOZ, E GUNGER, A YUKSEL Sakarya Tıp Dergisi 9 (4), 715-720, 2019 | | 2019 |
| 98 RADIATION SENSITIVITY AND DNA DAMAGE RESPONSES IN GLIOMA STEM CELLS S Ahmed, S Yildirim, M Alagoz, M Mannino, C Watts, E Amoah-Buahin, ... Radiotherapy and Oncology, S38, 2012 | | 2012 |
| The activation of C-ERBB2 receptor and loss of P53 function in breast cancer. M Alagoz University of Sussex, 1998 | | 1998 |
